Sign in

You're signed outSign in or to get full access.

Michiko Kurahashi

Director at VISHAY INTERTECHNOLOGYVISHAY INTERTECHNOLOGY
Board

About Michiko Kurahashi

Independent Class I director of Vishay Intertechnology since 2022; age 65; nominee for a new term expiring at the 2028 annual meeting. Former Chief Marketing Officer at AXIS Capital and currently an adjunct professor at New York University. Education: B.A. (University of Michigan – Ann Arbor), M.A. and Ph.D. in quantitative research/labor markets (Cornell University). Core credentials: corporate brand strategy, digital marketing, and global marketing leadership.

Past Roles

OrganizationRoleTenureCommittees/Impact
AXIS Capital (NYSE: AXS)Chief Marketing Officer2016–2020Launched “One AXIS” brand; implemented AI-driven marketing; streamlined processes
CIT BankHead of MarketingNot disclosedSenior marketing leadership
UBS AG; HSBC Private BankSenior marketing and communications rolesNot disclosedGlobal financial-services marketing

External Roles

OrganizationRoleTenureNotes
New York UniversityAdjunct ProfessorSince 2020Teaches marketing, communications, PR, and digital marketing technology

Board Governance

ItemDetail
Board statusIndependent director; Class I; director since 2022; current nominee for term ending 2028
Committee assignmentsCompensation Committee member (signatory on 2025 Proxy Compensation Committee Report for 2024)
Committee chair rolesNone disclosed for Dr. Kurahashi
Independence determinationBoard affirmed her independence under NYSE standards
AttendanceBoard met 8 times in 2024; each director attended ≥75% of Board and applicable committee meetings
Committee activity levels (2024)Audit (9), Nominating & Corporate Governance (4), Compensation (6); Executive Committee met formally 1 time (plus informal sessions)
Executive sessionsIndependent directors met in regularly scheduled executive sessions
Hedging/pledgingCompany prohibits hedging, short sales, transactions in publicly traded options, and pledging of Company stock
ClawbackDodd-Frank/NYSE-compliant clawback policy adopted Aug 15, 2023
Say-on-Pay (prior cycle)>94% approval in 2024; viewed as endorsement of program

Fixed Compensation

Plan terms for non-employee directors (2024):

  • Annual cash retainer: $70,000; Audit member +$12,000 (Chair +$30,000); Compensation member +$10,000 (Chair +$20,000); NCG member +$5,000 (Chair +$15,000). No per-meeting fees.

Dr. Kurahashi – 2024 cash compensation:

ComponentAmount (USD)
Cash retainer$70,000
Committee fees$0 (cash total equals base retainer)
Total cash$70,000

Notes: The 2025 proxy shows Dr. Kurahashi as a Compensation Committee member (and signatory) when reporting on 2024 compensation; 2024 fee table reflects no committee cash for her for 2024.

Performance Compensation

Non-employee director equity structure (2024):

  • Annual RSU grant on first trading day of the year sized at $180,000 “incentive value” ÷ prior year-end close; cliff vests in 3 years or ratably upon earlier cessation of service (other than for cause); accelerates on change-in-control. Grant-date fair value differs from incentive value due to ASC 718 treatment.

Dr. Kurahashi – 2024 equity compensation and vesting:

MetricDetail
2024 stock awards (grant-date fair value)$168,202
VestingCliff in 3 years (or ratably on earlier cessation of service, other than for cause)
Change-in-controlRSU vesting accelerates upon a change-in-control
OptionsCompany generally did not grant stock options/SARs in 2024

Other Directorships & Interlocks

CategoryDetail
Current public company boardsNo other public company directorships disclosed in her biography
Compensation Committee interlocksNone (committee members not officers/employees; no interlocks)

Expertise & Qualifications

  • Marketing/Brand/Digital: Deep corporate brand strategy and AI-driven/digital marketing expertise; global experience across financial services and insurance.
  • Academia/Thought leadership: Adjunct professor teaching executives and students on marketing and digital tech.
  • Qualifications flagged by Board: Leadership, complementary industry, global perspective, marketing expertise.

Equity Ownership

ItemAmount / Status
Beneficial ownership (common)8,166 shares; <1% of class/voting power
Director RSUs outstanding (12/31/24)24,084 units
Ownership guidelinesRequired ≥5x annual cash retainer; 5-year phase-in; measurement each January
Compliance status (as of Jan 2, 2025)Compliant
Hedging/PledgingProhibited for directors

Governance Assessment

  • Strengths

    • Independent status affirmed; serves on the all-independent Compensation Committee and signed the committee’s report, indicating active governance engagement on pay-for-performance oversight.
    • Solid alignment: compliant with director stock ownership guidelines; receives equity retainer with three-year vesting; hedging/pledging prohibited.
    • Attendance threshold met; Board held regular executive sessions of independent directors.
  • Risks/Watch items

    • Dual-class voting structure and concentrated voting power in family trusts (e.g., 44.4% voting power cited for a family co-trustee), which can diminish minority shareholder influence and increase scrutiny on board independence—even for independent directors.
    • 2024 director fee table shows no committee cash for Dr. Kurahashi despite her Compensation Committee report signatory status; investors may wish to confirm timing of committee appointments relative to the 2024 fee period.
  • Investor confidence signals

    • Corporate governance framework includes formal clawback and anti-hedging/pledging policies, and annual board self-evaluations; Audit, Compensation, and NCG Committees are fully independent.
    • Strong Say-on-Pay support (>94% in 2024).